NCT01873014

Brief Summary

safe study of Chinese Herbs to Treat Thyroid Diseases With Different Iodine

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
400

participants targeted

Target at P75+ for phase_1

Timeline
Completed

Started Jun 2012

Longer than P75 for phase_1

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2012

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

March 7, 2013

Completed
3 months until next milestone

First Posted

Study publicly available on registry

June 7, 2013

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2016

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2016

Completed
Last Updated

February 17, 2016

Status Verified

May 1, 2012

Enrollment Period

4.3 years

First QC Date

March 7, 2013

Last Update Submit

February 14, 2016

Conditions

Thyroid Diseases

Outcome Measures

Primary Outcomes (1)

  • diameter，number of the tumor

    3 months

Study Arms (2)

high Iodine intake

EXPERIMENTAL
Drug: chinese herbs-I

low Iodine intake

ACTIVE COMPARATOR
Drug: chinese herbs-II

Interventions

chinese herbs-IDRUG

two agent per day, twice a day

high Iodine intake
chinese herbs-IIDRUG

two agent per day, twice a day

low Iodine intake

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patient with thyroid diseases

You may not qualify if:

  • not meet the diagnostic criteria,women with pregnancy or lactation ,drug allergy ,need surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Thyroid Diseases

Condition Hierarchy (Ancestors)

Endocrine System Diseases

Study Officials

  • yu yang, doctor

    doctor

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 7, 2013

First Posted

June 7, 2013

Study Start

June 1, 2012

Primary Completion

October 1, 2016

Study Completion

December 1, 2016

Last Updated

February 17, 2016

Record last verified: 2012-05